Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting.
J Oncol Pharm Pract
; 28(1): 24-30, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-33349148
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Dexamethasone
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2022
Type:
Article
Affiliation country:
Italy